Harvard BioscienceHBIO
13F holders, Q4 2024 (December 31)1holders
0new positions
0sold out
$2.11avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Harvard Bioscience Inc. (HBIO) in their 13F filings, unchanged from Q3 2024. 0 opened new positions and 0 sold out. The largest holder was Pension & Wealth Management Advisors, Inc. ($13K).
- Company
- Harvard Bioscience Inc.
- CUSIP
- 416906204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 575 shares bought, net +575 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Pension & Wealth Management Advisors, Inc. | 0.01% | Add +10.7% | 5,950 | $13K |
"% of holder's portfolio" is HBIO's weight in each manager's 13F, not the share of Harvard Bioscience Inc. the manager owns.